DCEG staff members often receive scientific and professional society awards and recognition. In addition, they present their research at scientific conferences and participate in other events. Read about current DCEG people in the news below, and view an archive of past people in the news.
Megan Frone, M.S., C.G.C., and Nicolas Wentzensen, M.D., M.P.H. represented the Division and the National Cancer Institute on important—and very different—public platforms: Facebook and Capitol Hill. Read more about these events communicating DCEG research.
In October 2018, researchers at the National Cancer Institute hosted a meeting entitled, “IFN Lambda: Disease Impact and Translational Potential,” on the campus of the National Institutes of Health in Bethesda, Maryland. Read more about the IFN Lambda meeting.
Jonas S. Almeida, Ph.D., has been appointed Chief Data Scientist in DCEG. He is internationally recognized for his work on integrative biomedical applications that combine systems biology, computational statistics, and software engineering. Read more about Dr. Almeida.
New consensus-based guidelines for the clinical management of adult patients with Myotonic Dystrophy type I (DM1) were based in part on research by investigators in the Clinical Genetics Branch. Read more about how DCEG's research influence the DM1 guidelines.
Michele Morin Doody, M.S., a staff scientist in the Radiation Epidemiology Branch (REB), retired at the end of December 2018 after more than 30 years of federal service. Ms. Doody managed a case-control study of diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma in the Kaiser HMO setting. Read more about Michele Doody's retirement.
On December 11, 2018, Professor Helga Ögmundsdóttir from the University of Iceland presented a seminar, “Genetic predisposition to Waldenström's macroglæobulinemia - lessons from family studies”. Read more about Dr. Ögmundsdóttir's seminar.
In December, Ludmila Prokunina-Olsson, Ph.D., was appointed Chief of the Laboratory of Translational Genomics (LTG); she had been serving as Acting Chief since February 2018. Read more about Dr. Prokunina-Olsson's appointment.
DCEG Director Stephen Chanock highlighted new developments across the Division, recognized outstanding contributions from fellows and investigators. Read more about the 2018 Fall Town Hall meeting.
On November 8, 2018, many deserving DCEG staff were recognized at the NCI Director’s Award ceremony. Read more about the NCI Director's awards and their recipients.
Dr. Steven Simon was recognized by HHS for his service on Special Exposure Cohort Administrative Review Panels for the Energy Employees Occupational Illness Compensation Program Act of 2000. Read more about his award.
In October 2018, Regina G. Ziegler, Ph.D., M.P.H., retired after nearly 40 years of service to the National Cancer Institute. Dr. Ziegler is widely recognized for her expertise in nutritional epidemiology, incorporating circulating biomarkers into epidemiologic studies, and facilitating the development of assays needed by cancer epidemiologists. Read more about Dr. Ziegler.
DCEG’s communications team and scientific staff upgraded the user interface of NCI risk assessment tools that allow health professionals to quickly assess patients’ risk of developing breast or colorectal cancer. Read more about the redesign.
Dr. Dale Sandler, Chief of the Epidemiology Branch of the National Institute of Environmental Health Sciences (NIEHS) was a DCEG Visiting Scholar. Her seminar was entitled, “Prospective Studies of Environment and Health.” She focused her discussion on the design, execution, and results of the Gulf Long-term Follow-up Study (GuLF), a massive undertaking she coordinated to investigate health effects among workers involved in the clean up of the 2010 Deepwater Horizon oil rig disaster in the Gulf of Mexcio. Read more about Dr. Sandler's visit.
Dr. Gretchen Gierach was appointed Deputy Chief of the Integrative Tumor Epidemiology Branch. Read more about Dr. Gierach’s move.
Aimée R. Kreimer, Ph.D., senior investigator in the Infections and Immunoepidemiology Branch, received the NIH Director’s Award in the Scientific/Medical category in recognition of her outstanding achievements in human papillomavirus (HPV) cancer research and leadership in the Costa Rica HPV Vaccine Trial. Read more about Dr. Kreimer's award.
In October 2018, Kevin Brown, Ph.D., was awarded scientific tenure by the NIH and promoted to senior investigator in the Laboratory of Translational Genomics. Dr. Brown’s research is focused on identifying cancer genetic susceptibility loci and the functional pathways through which they affect risk, primarily for melanoma. Read more about Dr. Brown.
Brittny Davis Lynn was selected as a 2018 Rising Star in Biomedical Research and has been invited to speak at a related training workshop for female and under-represented minorities in biomedical research. Read more about Brittny Davis Lynn's recognition as a Rising Star.
In August 2018, Douglas R. Lowy, M.D., and John T. Schiller, Ph.D., were appointed as adjunct investigators in the DCEG Epidemiology and Biostatistics Program. Dr. Lowy is the NCI Deputy Director and Chief of the Laboratory of Cellular Oncology in the NCI Center for Cancer Research (CCR), and Dr. Schiller is the Deputy Chief and Head of the Neoplastic Disease Section of the Laboratory of Cellular Oncology in CCR. Read more about Drs. Lowy and Schiller.
AuthorArranger is a free web tool designed to help authors of research manuscripts generate correctly formatted title pages for manuscript journal submission in a fraction of the time it takes to create the pages manually. Learn more about AuthorArranger.
DCEG fellows and staff members presented exciting new statistical methods developed to solve important analytic problems in cancer epidemiology and genetics at the Joint Statistical Meeting in Vancouver, Canada From July 28- August 2, 2018. Read more about the JSM presentations.
Starting in 2019, the Division of Cancer Epidemiology and Genetics (DCEG) will offer training to clinically-focused investigators through the NCI’s Clinical Investigator Development Program (CIDP). Trainees will have the opportunity to conduct research in cancer genetics and epidemiology alongside investigators in DCEG. Read more about the Clinical Investigator Development Program.
In May 2018, Dr. Gary D. Wu of the University of Pennsylvania, gave the sixth Arthur Schatzkin Distinguished Lecture in Nutritional Epidemiology, entitled “Diet, the Gut Microbiome, and its Metabolome in Health and Disease”. Read more about Dr. Wu's Schatzkin lecture.
DCEG Intramural Research Awards (IRAs) are competitive funding opportunities designed to foster creative, high-impact research by fellows and tenure-track investigators. Read more about the Intramural Research Award winners.
On June 18th, Ruth Pfeiffer, Ph.D., senior investigator in the Biostatistics Branch, delivered the 8th Mildred Scheel Lecture in Heidelberg, Germany, titled "Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening". Read more about Dr. Pfeiffer's lecture.
In June, DCEG announced six winners of the 2018 DCEG Informatics Tool Challenge, a competitive funding program that supports innovative approaches to enhance epidemiological methods, data collection, analysis, and other research efforts of the Division using modern technology and informatics. Read more about the six winning proposals.
In June 2018, Margaret Tucker, M.D., Director of the DCEG Human Genetics Program, retired after 40 years of service to the National Cancer Institute (NCI). Dr. Tucker led a superbly productive program of epidemiologic and interdisciplinary studies with innovative clinical and laboratory components. Her landmark scientific contributions have substantively improved our understanding of the mechanisms underlying familial cancers and predisposition to multiple malignancies. Read more about Dr. Tucker's legacy.
Sharon A. Savage, M.D., Chief of the Clinical Genetics Branch, has been appointed as the new Clinical Director for DCEG. She will be responsible for ensuring patient safety, research integrity, and the responsible stewardship of research funding for all DCEG clinical activities. Learn more about Dr. Savage's appointment.
The tenth annual DCEG Fellows’ Symposium was held in March 2018 on the NIH main campus. The theme for this year’s symposium was “Defining Cancer Risk: Does G (Genetics) × E (Environment) = Me”. Read more about the 2018 Annual Fellows' Training Symposium.
In April 2018, DCEG welcomed Robert Burk, M.D., Professor at the Albert Einstein College of Medicine, as the inaugural Sholom Wacholder Distinguished Lecturer in Quantitative Health Sciences. Read about the Wacholder lecture.
Nicolas Wentzensen, M.D., Ph.D., senior investigator and Deputy Chief, Clinical Genetics Branch, received the Distinguished Scientific Award from the ASCCP for his leadership in the Colposcopy Standards project. Read more about Dr. Wentzensen's award.
In April 2018, several DCEG staff members took part in the annual meeting of the American Association for Cancer Research (AACR) in Chicago, Illinois. This five-day event highlighted the latest scientific advances in basic, clinical, and epidemiologic cancer research. Read more about DCEG participation in the AACR meeting.
In April 2018, Martha Linet, M.D., M.P.H., senior investigator in the Radiation Epidemiology Branch (REB), received the Career Achievement Award from the U.S. Department of Health and Human Services. This award, among the highest granted by the Department, recognizes Dr. Linet’s decades of international leadership in epidemiology. Read about Dr. Linet's award.
In April 2018, Paul Albert, Ph.D., Chief of the Biostatistics Branch, was honored with the Robert W. Makuch Distinguished Lecture in Biostatistics by the University of Connecticut Department of Statistics. His lecture was titled “Innovative approaches to the statistical analysis of circadian rhythm data: Uncovering the patterns of life.” Read more about this honor.
In March 2018, Rouf Banday, Ph.D., research fellow in the Laboratory of Translational Genomics (LTG), was awarded the Robert A. Welch Fellowship. The fellowship includes funds to be used for travel to attend a scientific conference as well as for research resources. Read more about Dr. Banday's award.
DCEG postdoctoral fellow Megan Clarke, Ph.D., M.H.S., was selected for the 2018 William G. Coleman Minority Health and Health Disparities Research Innovation Award for her proposal, “Evaluating the Associations of Symptom Appraisal and Barriers to Care with Endometrial Cancer Presentation and Outcomes in a Diverse Population.” Learn more about Dr. Clarke's award.
Two postdoctoral fellows were recognized with prestigious designations by NCI. Talia Wegman-Ostrosky, M.D., PhD., was accepted into the Diversity Career Development Program (DCDP), and Manila Hada, Ph.D., was awarded the Sallie Rosen Kaplan (SRK) Postdoctoral Fellowship for Women Scientists for 2018. Read more about these designations.
In March 2018, Melissa Bondy, Ph.D., M.S., Professor in the Department of Medicine at Baylor College of Medicine in Houston, TX, spent two days at DCEG as a Visiting Scholar. An expert in genetic susceptibility and heritability for brain and breast cancer, Dr. Bondy has an additional strong interest in health disparities. Read more about Dr. Bondy's visit.
In March 2018, Wenyi Wang, Ph.D., Associate Professor in the Department of Bioinformatics and Computational Biology at the University of Texas MD Anderson Cancer Center, visited DCEG to give a seminar and meet with staff. Read more about Dr. Wang's visit.
In February 2018, Joseph F. Fraumeni, Jr., M.D., received special recognition from his fellow Scientific Directors at the National Institutes of Health (NIH). Read more about Dr. Fraumeni's award.
Ludmila Prokunina-Olsson, Ph.D., was appointed Acting Chief of the DCEG Laboratory of Translational Genomics (LTG) in February 2018. Dr. Prokunina-Olsson explores the connections between GWAS-identified genetic susceptibility variants and molecular phenotypes of importance for cancer in general, and bladder cancer, in particular. Read more about Dr. Prokunina-Olsson.
Charles E. Land, Ph.D., an internationally acclaimed statistical expert on radiation risk assessment, died January 25, 2018. He retired in August 2009 from the Radiation Epidemiology Branch (REB) in the NCI Division of Cancer Epidemiology and Genetics (DCEG), after a 34-year career. Dr. Land will be remembered not only for his pioneering work in modern radiation dose-response analysis and modeling of low-dose cancer risk, but also as a delightful humble man who loved his family, Japan, music, and his work. He was a generous mentor and beloved friend to his REB colleagues and many others. Read more about Dr. Land.
Mr. Jun-mo Nam, formerly a biostatistician in the Division of Cancer Epidemiology and Genetics, National Cancer Institute, passed away on January 4, 2018. Mr. Nam was admired for his comportment and devotion to work and the NCI mission. He authored about 80 publications in biostatistical methods and the medical sciences. Read more about Mr. Nam.
DCEG hosted a lecture in late January by the eminent statistician Sir David Cox, Ph.D. Speaking to a large audience via videoconference from his office in Oxford, England, Sir David presented his thoughts on broad unifying principles and new challenges in statistics. Read more about the lecture.
On January 9, 2018, DCEG scientists participated in the annual NCI Intramural Scientific Investigators Retreat. Tenure-track investigator Lisa Mirabello, Ph.D., M.S., gave an invited lecture on “HPV genomic insights into cervical carcinogenesis and HPV natural history.” Read more about the retreat.
In December 2017, Mark Purdue, Ph.D., was awarded scientific tenure by the NIH and promoted to senior investigator in the Occupational and Environmental Epidemiology Branch. Dr. Purdue investigates cancer risk associated with occupational exposures, circulating immune markers as they relate to risk for non-Hodgkin lymphoma (NHL) and multiple myeloma, and genetic susceptibility to renal cell carcinoma. Read more about Dr. Purdue.
In September 2017, HPV World, the only scientific newsletter on HPV research in the world, published its third edition, focusing on questions related to single-dose efficacy of the HPV vaccines. Aimée R. Kreimer, Ph.D., senior investigator in the Infections and Immunoepidemiology Branch, served as the scientific guest editor. Read more about the new HPV World issue.
Danping Liu, Ph.D., has joined the Biostatistics Branch as a tenure-track investigator. Most recently, he was a tenure-track investigator at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) where he specialized in the analysis of biomarker, diagnostic, and longitudinal data. Learn more about Dr. Liu.
In November 2017, the Oxford University Press published the fourth edition of Cancer Epidemiology and Prevention edited by Michael Thun, M.D, M.S. (lead editor) and DCEG senior investigator Martha Linet, M.D., M.P.H., James Cerhan, M.D., Ph.D., Christopher Haiman, Sc.D., and David Schottenfeld, M.D., M.Sc. (co-editors). Learn more about the new textbook.
DCEG investigators played leading roles in the 2017 NCI Cohort Consortium Annual Meeting, which took place on November 13th and 14th at the NCI Shady Grove campus. Read more about the meeting.
In October 2017, dozens of DCEG scientists attended or presented at the annual meeting of the American Society for Human Genetics (ASHG). This meeting offers trainees and investigators the opportunity to meet with collaborators, share their latest research findings, and learn about the cutting-edge science taking place around the globe. Learn more about DCEG presentations at ASHG.
In October 2017, investigators in the Clinical Genetics Branch (CGB) hosted a workshop entitled “Vascular Complications in Dyskeratosis Congenita.” The two-day meeting brought together researchers and advocates to discuss the state of the science for such complications, and to brainstorm future avenues for research. Learn more about the workshop.
In October, several DCEG staff members were honored for their outstanding leadership and commitment to NCI at the NCI Director's Awards ceremony. Read about the DCEG award recipients.
In October 2017, postdoctoral fellow Talia Wegman-Ostrosky, M.D., Ph.D., of the Clinical Genetics Branch, was one of five NIH trainees selected to present their research at the Annual Science Symposium of the Society for Advancement of Chicanos/Hispanics and Native Americans in Science, NIH Chapter (NIH-SACNAS). Learn more about Dr. Wegman-Ostrosky's NIH-SACNAS presentation.